Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pickering syndrome: acute heart failure with an unexpected actor].

Hipertension y riesgo vascular·2021
Same author

Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low Titers.

Transplantation proceedings·2016
Same author

Safety and efficacy of induction treatment with low thymoglobulin doses in kidney transplantation from expanded-criteria donors.

Transplantation proceedings·2015
Same author

Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.

Transplantation proceedings·2012
Same author

Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.

Transplantation proceedings·2011
Same author

[Delayed spontaneous rupture of the kidney graft].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2010

Related Experiment Video

Updated: May 30, 2026

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Delayed graft function after renal transplantation: an unresolved problem.

E Gavela Martínez1, L M Pallardó Mateu, A Sancho Calabuig

  • 1Servicio de Nefrología, Hospital U. Dr Peset, Valencia, Spain. egavelam@senefro.org

Transplantation Proceedings
|August 16, 2011
PubMed
Summary
This summary is machine-generated.

Delayed graft function (DGF) in kidney transplants is linked to donor/recipient age, hypertension history, and longer cold ischemia times. DGF significantly reduces graft and patient survival rates, highlighting the need for interventions like shortening cold ischemia.

Related Experiment Videos

Last Updated: May 30, 2026

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
08:49

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

Published on: August 2, 2024

Area of Science:

  • Nephrology
  • Transplantation Surgery
  • Medical Research

Background:

  • Delayed graft function (DGF) is a common complication in renal transplantation.
  • Donor characteristics significantly influence DGF occurrence and outcomes.
  • Identifying DGF risk factors is crucial for improving graft and patient survival.

Purpose of the Study:

  • To investigate the risk factors associated with DGF in renal transplant recipients.
  • To analyze the impact of DGF on graft and patient survival.
  • To identify modifiable factors for DGF prevention.

Main Methods:

  • Retrospective analysis of 507 renal transplant recipients.
  • DGF defined as dialysis requirement within the first week post-transplant.
  • Multivariate analysis to identify independent risk factors for DGF.

Main Results:

  • DGF occurred in 36.8% of patients.
  • Independent risk factors for DGF included recipient age, recipient smoking habit, and donor history of hypertension.
  • DGF was associated with significantly lower 5-year graft and patient survival rates.

Conclusions:

  • DGF is influenced by donor, recipient, and surgical factors.
  • Recipient age, smoking habit, and donor hypertension are independent DGF risk factors.
  • Reducing cold ischemia time is a potential strategy to mitigate DGF and improve transplant outcomes.